Malik, M.; Michalak, M.; Radecka, B.; Gełej, M.; Jackowska, A.; Filipczyk-Cisarż, E.; Hetman, K.; Foszczyńska-Kłoda, M.; Kania-Zembaczyńska, B.; Mańka, D.;
et al. Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. J. Clin. Med. 2021, 10, 5107.
https://doi.org/10.3390/jcm10215107
AMA Style
Malik M, Michalak M, Radecka B, Gełej M, Jackowska A, Filipczyk-Cisarż E, Hetman K, Foszczyńska-Kłoda M, Kania-Zembaczyńska B, Mańka D,
et al. Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. Journal of Clinical Medicine. 2021; 10(21):5107.
https://doi.org/10.3390/jcm10215107
Chicago/Turabian Style
Malik, Mateusz, Maciej Michalak, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż, Katarzyna Hetman, Małgorzata Foszczyńska-Kłoda, Beata Kania-Zembaczyńska, Danuta Mańka,
and et al. 2021. "Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil" Journal of Clinical Medicine 10, no. 21: 5107.
https://doi.org/10.3390/jcm10215107
APA Style
Malik, M., Michalak, M., Radecka, B., Gełej, M., Jackowska, A., Filipczyk-Cisarż, E., Hetman, K., Foszczyńska-Kłoda, M., Kania-Zembaczyńska, B., Mańka, D., Orlikowska, M., Rogowska-Droś, H., & Bodnar, L.
(2021). Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. Journal of Clinical Medicine, 10(21), 5107.
https://doi.org/10.3390/jcm10215107
